NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 845 filers reported holding NOVARTIS A G in Q2 2014. The put-call ratio across all filers is 0.65 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,267,765 | -20.1% | 51,715 | -20.9% | 1.90% | -16.2% |
| Q2 2023 | $6,596,763 | +9.4% | 65,372 | -0.2% | 2.27% | +5.6% |
| Q1 2023 | $6,029,104 | -2.5% | 65,533 | -3.9% | 2.15% | -8.1% |
| Q4 2022 | $6,183,905 | +18.4% | 68,164 | -0.8% | 2.34% | +13.2% |
| Q3 2022 | $5,222,000 | -11.2% | 68,710 | -1.2% | 2.07% | +6.4% |
| Q2 2022 | $5,880,000 | -4.2% | 69,566 | -0.6% | 1.94% | +4.5% |
| Q1 2022 | $6,139,000 | +0.5% | 69,964 | +0.1% | 1.86% | +2.2% |
| Q4 2021 | $6,111,000 | +9.1% | 69,869 | +2.0% | 1.82% | +2.4% |
| Q3 2021 | $5,603,000 | -5.8% | 68,519 | +5.1% | 1.78% | -7.9% |
| Q2 2021 | $5,947,000 | +25.0% | 65,182 | +17.1% | 1.93% | +5.5% |
| Q1 2021 | $4,757,000 | +55.8% | 55,660 | +72.1% | 1.83% | +35.0% |
| Q4 2020 | $3,054,000 | +9.3% | 32,344 | +0.6% | 1.36% | -11.9% |
| Q3 2020 | $2,795,000 | -16.5% | 32,144 | -16.2% | 1.54% | -26.7% |
| Q2 2020 | $3,348,000 | +7.5% | 38,339 | +1.5% | 2.10% | -7.6% |
| Q1 2020 | $3,114,000 | -13.0% | 37,779 | -0.1% | 2.27% | +5.6% |
| Q4 2019 | $3,581,000 | +9.3% | 37,818 | +0.3% | 2.15% | +2.6% |
| Q3 2019 | $3,277,000 | -10.2% | 37,713 | -5.6% | 2.10% | -10.8% |
| Q2 2019 | $3,648,000 | +0.4% | 39,953 | +5.6% | 2.35% | -4.1% |
| Q1 2019 | $3,635,000 | +12.3% | 37,818 | +0.3% | 2.45% | -2.7% |
| Q4 2018 | $3,236,000 | -0.9% | 37,718 | -0.5% | 2.52% | +19.6% |
| Q3 2018 | $3,265,000 | +14.4% | 37,903 | +0.3% | 2.11% | +13.3% |
| Q2 2018 | $2,854,000 | +0.8% | 37,793 | +7.9% | 1.86% | +3.9% |
| Q1 2018 | $2,832,000 | -4.6% | 35,038 | -0.9% | 1.79% | -3.5% |
| Q4 2017 | $2,967,000 | -1.1% | 35,348 | +1.1% | 1.85% | -8.3% |
| Q3 2017 | $3,000,000 | -48.5% | 34,948 | -49.9% | 2.02% | -9.5% |
| Q2 2017 | $5,820,000 | +125.3% | 69,726 | +100.5% | 2.23% | +15.0% |
| Q1 2017 | $2,583,000 | +5.2% | 34,783 | +3.2% | 1.94% | +1.5% |
| Q4 2016 | $2,455,000 | -16.2% | 33,708 | -9.1% | 1.91% | -18.6% |
| Q3 2016 | $2,928,000 | -2.8% | 37,088 | +1.5% | 2.35% | -6.8% |
| Q2 2016 | $3,013,000 | +17.0% | 36,523 | +2.7% | 2.52% | +9.0% |
| Q1 2016 | $2,576,000 | -7.9% | 35,573 | +9.4% | 2.31% | -7.9% |
| Q4 2015 | $2,797,000 | -4.2% | 32,518 | +2.4% | 2.51% | -8.3% |
| Q3 2015 | $2,920,000 | -8.9% | 31,768 | -2.5% | 2.74% | +4.7% |
| Q2 2015 | $3,204,000 | -1.6% | 32,583 | -1.4% | 2.61% | +0.8% |
| Q1 2015 | $3,257,000 | +3.8% | 33,038 | -2.4% | 2.59% | +6.0% |
| Q4 2014 | $3,138,000 | -8.1% | 33,864 | -6.6% | 2.44% | -14.5% |
| Q3 2014 | $3,414,000 | +3.8% | 36,273 | -0.2% | 2.86% | +4.3% |
| Q2 2014 | $3,290,000 | +5.4% | 36,343 | -1.0% | 2.74% | -3.3% |
| Q1 2014 | $3,121,000 | -31.0% | 36,718 | -34.7% | 2.84% | -32.7% |
| Q4 2013 | $4,520,000 | +5.1% | 56,233 | +0.3% | 4.22% | +7.2% |
| Q3 2013 | $4,300,000 | +8.7% | 56,058 | +0.2% | 3.94% | +7.3% |
| Q2 2013 | $3,957,000 | – | 55,968 | – | 3.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Martin Investment Management, LLC | 229,184 | $23,344,682 | 7.00% |
| Foresight Global Investors, Inc. | 97,500 | $9,397,737 | 5.23% |
| SCHARF INVESTMENTS, LLC | 1,425,745 | $145,226,322 | 4.34% |
| MANAGED ASSET PORTFOLIOS, LLC | 274,204 | $27,930,369 | 4.28% |
| GARLAND CAPITAL MANAGEMENT INC | 54,710 | $5,572,761 | 3.93% |
| PRENTISS SMITH & CO INC | 52,032 | $5,299,980 | 3.91% |
| WILKINS INVESTMENT COUNSEL INC | 130,950 | $13,339 | 3.61% |
| First Fiduciary Investment Counsel, Inc. | 145,731 | $14,844 | 3.48% |
| Cullen Capital Management, LLC | 2,714,809 | $276,530,464 | 3.23% |
| JOHN G ULLMAN & ASSOCIATES INC | 182,690 | $18,608,803 | 3.04% |